# Apidra Children & Adolescents Study

> **NCT01202474** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 100 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** INSULIN GLULISINE
- **DRUG:** INSULIN GLARGINE

## Key facts

- **NCT ID:** NCT01202474
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202474, "Apidra Children & Adolescents Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01202474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*